Available clinical evidence, however, does not support claims of anti-cancer effect, quality of life, or other outcomes from the use of mistletoe extract.
Thus, it is frequently used as macromolecular carriers for low molecular weight drugs (especially anti-cancer chemotherapeutic agents) to enhance therapeutic efficacy and limit side effects.
Test molecules that promote endothelial cell network formation are candidates for tissue regeneration therapies whereas test molecules that inhibit endothelial cell network formation are candidates for anti-cancer therapies.